The science of vaccines is rapidly advancing - despite the anti-vax movement
Sanofi SA SAN
News
Windward Bio Group IPO of 10.3M Shares Prices at $17 Each
Nurix Therapeutics Shares Plunge on Sanofi's Termination of Drug Development Program
Regeneron Pharma 3Q Sales Climb on Dupixent Growth
Sanofi CEO Sets Sights on Deals to Drive Turnaround — 2nd Update
Sanofi CEO Sets Sights on Deals to Drive Turnaround — Update
Sanofi CEO Sets Sights on Deals to Drive Turnaround
Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany
EU Accepts Sanofi's Concessions to End Antitrust Probe Over Vaccine Marketing — Update
EU Accepts Sanofi's Concessions to Settle Antitrust Probe Over Vaccine Marketing
Flu season is already here. Here's what to know about this year's flu shots.
Press Release : Availability of the aide-mémoire for Q3 2026 results
Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®
Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal — Update
Sanofi, Regeneron to Expand Alliance in Deal Valued at Up to $8 Billion
Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
European Pharma Leaders Push for National Reforms to Boost Investment
United States